Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1970 1
1971 1
1976 1
1977 1
1983 1
1984 1
1985 1
1986 4
1987 1
1988 2
1989 1
1990 1
1992 4
1993 3
1994 10
1995 8
1996 5
1997 6
1998 8
1999 6
2000 7
2001 5
2002 4
2003 7
2004 15
2005 18
2006 20
2007 36
2008 42
2009 48
2010 15
2011 20
2012 14
2013 6
2014 8
2015 5
2016 8
2017 11
2018 7
2019 6
2020 10
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 19218475

361 results
Results by year
Filters applied: . Clear all
Page 1
Calcineurin inhibitor nephrotoxicity.
Naesens M, Kuypers DR, Sarwal M. Naesens M, et al. Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508. doi: 10.2215/CJN.04800908. Clin J Am Soc Nephrol. 2009. PMID: 19218475 Free article. Review.
The CARI guidelines. Calcineurin inhibitors in renal transplantation: nephrotoxicity and calcineurin inhibitors.
Coates PT; Caring for Australians with Renal Impairment (CARI). Coates PT, et al. Nephrology (Carlton). 2007 Feb;12 Suppl 1:S85-7. doi: 10.1111/j.1440-1797.2006.00733.x. Nephrology (Carlton). 2007. PMID: 17316286 Review. No abstract available.
Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts.
Liptak P, Ivanyi B. Liptak P, et al. Nat Clin Pract Nephrol. 2006 Jul;2(7):398-404; quiz following 404. doi: 10.1038/ncpneph0225. Nat Clin Pract Nephrol. 2006. PMID: 16932468 Review.
Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.
Bai JP, Lesko LJ, Burckart GJ. Bai JP, et al. Pharmacotherapy. 2010 Feb;30(2):195-209. doi: 10.1592/phco.30.2.195. Pharmacotherapy. 2010. PMID: 20099993
[Calcineurin inhibitor nephrotoxicity in renal allografts].
Takeda A, Morozumi K. Takeda A, et al. Nihon Jinzo Gakkai Shi. 2011;53(4):610-4. Nihon Jinzo Gakkai Shi. 2011. PMID: 21688481 Review. Japanese. No abstract available.
Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity.
Metalidis C, Lerut E, Naesens M, Kuypers DR. Metalidis C, et al. Transplantation. 2011 May 27;91(10):1098-102. doi: 10.1097/TP.0b013e3182177502. Transplantation. 2011. PMID: 21544031
The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity.
Hesselink DA, Bouamar R, van Gelder T. Hesselink DA, et al. Ther Drug Monit. 2010 Aug;32(4):387-93. doi: 10.1097/FTD.0b013e3181e44244. Ther Drug Monit. 2010. PMID: 20571464 Review.
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
Vivarelli M, Cucchetti A, La Barba G, Ravaioli M, Del Gaudio M, Lauro A, Grazi GL, Pinna AD. Vivarelli M, et al. Ann Surg. 2008 Nov;248(5):857-62. doi: 10.1097/SLA.0b013e3181896278. Ann Surg. 2008. PMID: 18948815
Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
Gaston RS. Gaston RS. Clin J Am Soc Nephrol. 2009 Dec;4(12):2029-34. doi: 10.2215/CJN.03820609. Epub 2009 Oct 22. Clin J Am Soc Nephrol. 2009. PMID: 19850771 Free article. Review.
Chronic calcineurin inhibitor nephrotoxicity-lest we forget.
Chapman JR. Chapman JR. Am J Transplant. 2011 Apr;11(4):693-7. doi: 10.1111/j.1600-6143.2011.03504.x. Am J Transplant. 2011. PMID: 21446974 Free article.
361 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback